Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.

Neuroscience Letters(2017)

引用 36|浏览14
暂无评分
摘要
•HDAC6 is evidently induced in dopaminergic neurons in Parkinson’s disease (PD).•Acetylation levels of Prx1 and Prx2 decrease after 6-OHDA treatment.•Pharmacological inhibition of HDAC6 ameliorates dopaminergic neurotoxicity.
更多
查看译文
关键词
Histone deacetylase 6,Tubastatin A,Peroxiredoxin,Acetylation,Parkinson's disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要